Erratum: Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: A prospective, multicentre, phase II, single-arm study (British Journal of Haematology (2006) 135 (174-183))

J. R. Berenson, R. Boccia, D. Siegel, M. Bozdech, A. Bessudo, E. Stadtmauer, J. T. Pomeroy, R. Steis, M. Flam, J. Lutzky, S. Jilani, J. Volk, S. F. Wong, R. Moss, R. Patel, D. Ferretti, K. Russell, R. Louie, H. S. Yeh, R. A. Swift

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)173-174
Number of pages2
JournalBritish Journal of Haematology
Volume136
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Cite this